Stockreport

Intersect ENT Submits New Drug Application to FDA for Office-Based RESOLVE Steroid Releasing Implant for Recurrent Chronic Sinus Disease

Intersect ENT, Inc.  (XENT) 
Last intersect ent, inc. earnings: 2/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intersectent.com/investor-relations
PDF Submission Supported by Four Clinical Studies Evaluating Safety and Effectiveness MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (N [Read more]